525 related articles for article (PubMed ID: 12438562)
1. Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications.
Wells L; Vosseller K; Cole RN; Cronshaw JM; Matunis MJ; Hart GW
Mol Cell Proteomics; 2002 Oct; 1(10):791-804. PubMed ID: 12438562
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of both protein expression and serine / threonine post-translational modifications through stable isotope labeling with dithiothreitol.
Vosseller K; Hansen KC; Chalkley RJ; Trinidad JC; Wells L; Hart GW; Burlingame AL
Proteomics; 2005 Feb; 5(2):388-98. PubMed ID: 15648052
[TBL] [Abstract][Full Text] [Related]
3. Identification of the major site of O-linked beta-N-acetylglucosamine modification in the C terminus of insulin receptor substrate-1.
Ball LE; Berkaw MN; Buse MG
Mol Cell Proteomics; 2006 Feb; 5(2):313-23. PubMed ID: 16244361
[TBL] [Abstract][Full Text] [Related]
4. Nucleocytoplasmic glycosylation, O-GlcNAc: identification and site mapping.
Zachara NE; Cheung WD; Hart GW
Methods Mol Biol; 2004; 284():175-94. PubMed ID: 15173616
[TBL] [Abstract][Full Text] [Related]
5. Synapsin-1 and tau reciprocal O-GlcNAcylation and phosphorylation sites in mouse brain synaptosomes.
Kang MJ; Kim C; Jeong H; Cho BK; Ryou AL; Hwang D; Mook-Jung I; Yi EC
Exp Mol Med; 2013 Jun; 45(6):e29. PubMed ID: 23807304
[TBL] [Abstract][Full Text] [Related]
6. Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation.
Whelan SA; Hart GW
Circ Res; 2003 Nov; 93(11):1047-58. PubMed ID: 14645135
[TBL] [Abstract][Full Text] [Related]
7. Discovery of O-GlcNAc-modified proteins in published large-scale proteome data.
Hahne H; Gholami AM; Kuster B
Mol Cell Proteomics; 2012 Oct; 11(10):843-50. PubMed ID: 22661428
[TBL] [Abstract][Full Text] [Related]
8. Mapping of O-linked beta-N-acetylglucosamine modification sites in key contractile proteins of rat skeletal muscle.
Hédou J; Bastide B; Page A; Michalski JC; Morelle W
Proteomics; 2009 Apr; 9(8):2139-48. PubMed ID: 19322778
[TBL] [Abstract][Full Text] [Related]
9. Identification of O-GlcNAc sites on proteins.
Whelan SA; Hart GW
Methods Enzymol; 2006; 415():113-33. PubMed ID: 17116471
[TBL] [Abstract][Full Text] [Related]
10. O-linked N-acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry.
Vosseller K; Trinidad JC; Chalkley RJ; Specht CG; Thalhammer A; Lynn AJ; Snedecor JO; Guan S; Medzihradszky KF; Maltby DA; Schoepfer R; Burlingame AL
Mol Cell Proteomics; 2006 May; 5(5):923-34. PubMed ID: 16452088
[TBL] [Abstract][Full Text] [Related]
11. Glycosylation of the murine estrogen receptor-alpha.
Cheng X; Hart GW
J Steroid Biochem Mol Biol; 2000 Dec; 75(2-3):147-58. PubMed ID: 11226831
[TBL] [Abstract][Full Text] [Related]
12. β-N-Acetylglucosamine (O-GlcNAc) is a novel regulator of mitosis-specific phosphorylations on histone H3.
Fong JJ; Nguyen BL; Bridger R; Medrano EE; Wells L; Pan S; Sifers RN
J Biol Chem; 2012 Apr; 287(15):12195-203. PubMed ID: 22371497
[TBL] [Abstract][Full Text] [Related]
13. Dynamic interplay between O-linked N-acetylglucosaminylation and glycogen synthase kinase-3-dependent phosphorylation.
Wang Z; Pandey A; Hart GW
Mol Cell Proteomics; 2007 Aug; 6(8):1365-79. PubMed ID: 17507370
[TBL] [Abstract][Full Text] [Related]
14. Selective detection and site-analysis of O-GlcNAc-modified glycopeptides by beta-elimination and tandem electrospray mass spectrometry.
Greis KD; Hayes BK; Comer FI; Kirk M; Barnes S; Lowary TL; Hart GW
Anal Biochem; 1996 Feb; 234(1):38-49. PubMed ID: 8742080
[TBL] [Abstract][Full Text] [Related]
15. Discovery and confirmation of O-GlcNAcylated proteins in rat liver mitochondria by combination of mass spectrometry and immunological methods.
Cao W; Cao J; Huang J; Yao J; Yan G; Xu H; Yang P
PLoS One; 2013; 8(10):e76399. PubMed ID: 24098488
[TBL] [Abstract][Full Text] [Related]
16. Mapping of O-GlcNAc sites of 20 S proteasome subunits and Hsp90 by a novel biotin-cystamine tag.
Overath T; Kuckelkorn U; Henklein P; Strehl B; Bonar D; Kloss A; Siele D; Kloetzel PM; Janek K
Mol Cell Proteomics; 2012 Aug; 11(8):467-77. PubMed ID: 22556278
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel sites of O-N-acetylglucosamine modification of serum response factor using quadrupole time-of-flight mass spectrometry.
Chalkley RJ; Burlingame AL
Mol Cell Proteomics; 2003 Mar; 2(3):182-90. PubMed ID: 12684542
[TBL] [Abstract][Full Text] [Related]
18. Nucleocytoplasmic O-glycosylation: O-GlcNAc and functional proteomics.
Vosseller K; Wells L; Hart GW
Biochimie; 2001 Jul; 83(7):575-81. PubMed ID: 11522385
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive mapping of O-GlcNAc modification sites using a chemically cleavable tag.
Griffin ME; Jensen EH; Mason DE; Jenkins CL; Stone SE; Peters EC; Hsieh-Wilson LC
Mol Biosyst; 2016 May; 12(6):1756-9. PubMed ID: 27063346
[TBL] [Abstract][Full Text] [Related]
20. Alternative O-glycosylation/O-phosphorylation of serine-16 in murine estrogen receptor beta: post-translational regulation of turnover and transactivation activity.
Cheng X; Hart GW
J Biol Chem; 2001 Mar; 276(13):10570-5. PubMed ID: 11150304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
